$BHVN$xbi
Started a position in $BHVN this morning, though I wish that I went bigger with it.
Here’s my take.
$BHVN offloading opakalim to SK Biopharma was a double win for shareholders:
1) upfront funding for a company that needs the $$ influx, and more importantly
